-
RB Loss in Resistant EGFR Mutant Lung Adenocarcinomas that Transform to Small Cell Lung Cancer
Study
EGAS00001001102
-
MiR expression profiles of paired primary colorectal cancerand metastases by next-generation sequencing
Study
EGAS00001001127
-
mFAST-SeqS
Study
EGAS00001001133
-
Human breast transcriptome analysis
Study
EGAS00001004665
-
MINCR is a MYC-induced lncRNA able to modulate MYC’s transcriptional network in Burkitt lymphoma cells
Study
EGAS00001001199
-
The transcription factor GABP selectively binds and activates the mutant TERT promoter in cancer
Study
EGAS00001001242
-
Intra-tumor heterogeneity and clonal evolution patterns towards platinum-resistant high-grade serous ovarian cancer
Study
EGAS00001001244
-
Drug screening and whole genome sequencing of primary cells and cell lines from ovarian cancer patients to associate genomic aberrations with in vitro drug sensitivities
Study
EGAS00001002239
-
Clinical Implications of Genomic Alterations in the Tumor and Circulation of Pancreatic Cancer Patients
Study
EGAS00001001257
-
single-cell RNA-Seq of colorectal cancer patient samples
Study
EGAS00001006665
-
Search for new loci and low-frequency variants influencing glioma risk by exome-array analysis
Study
EGAS00001001258
-
Whole exome sequencing of papillary thyroid carcinoma in the Chinese population
Study
EGAS00001001268
-
Novel Epigenetic Markers for Toxicity after Intraoperative and Conventional Radiotherapy for Breast Cancer
Study
EGAS00001001279
-
The Genomic Landscape of Response to EGFR Blockade in Colorectal Cancer
Study
EGAS00001001305
-
Genomic analysis of HPV positive versus HPV negative esophageal adenocarcinoma
Study
EGAS00001001340
-
A somatic reference standard for cancer genome sequencing with COLO829
Study
EGAS00001001385
-
Genetic and epigenetic characterization of adenoid cystic carcinoma
Study
EGAS00001001457
-
Characterization of T cell tumor infiltration in brain metastases through the analysis of the cerebrospinal fluid
Study
EGAS00001004751
-
Breast Cancer - Subtype defined by an amplification of the HER2 gene
Study
EGAS00001001431
-
Inherited damaging mutations in immune-related genes favour the development of genetically heterogeneous synchronous colorectal cancer.
Study
EGAS00001001461
-
Sequencing of serial plasma and multiregional tumor samples in a patient with metastatic breast cancer
Study
EGAS00001001466
-
WGS of MAPKi acquired resistant samples from patients and PDX models
Study
EGAS00001006874
-
Smart-seq3 scRNA-seq of cells from primary (OV2295) and metastatic (OV2295R2) high-grade serous ovarian cancer cell-line
Study
EGAS00001006868
-
Identification of cis-regulatory mutations generating de novo edges in personalized cancer gene regulatory networks
Study
EGAS00001002571
-
germline variants in children with hematological cancer
Study
EGAS00001006907